SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-377345"
 

Sökning: id:"swepub:oai:DiVA.org:uu-377345" > Pulmonary PET imagi...

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator

Schou, Magnus (författare)
Karolinska Institutet
Ewing, Par (författare)
AstraZeneca, Resp Inflammat & Autoimmun IMED Biotech Unit, Gothenburg, Sweden
Cselenyi, Zsolt (författare)
Karolinska Institutet
visa fler...
Fridén, Markus (författare)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,AstraZeneca, Resp Inflammat & Autoimmun IMED Biotech Unit, Gothenburg, Sweden
Takano, Akihiro (författare)
Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, SE-17176 Stockholm, Sweden;Stockholm Cty Council, SE-17176 Stockholm, Sweden
Halldin, Christer (författare)
Karolinska Institutet
Farde, Lars (författare)
Karolinska Institutet
visa färre...
 (creator_code:org_t)
2019-01-29
2019
Engelska.
Ingår i: EJNMMI Research. - : Springer Science and Business Media LLC. - 2191-219X. ; 9
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Positron emission tomography (PET) is a non-invasive molecular imaging technique that traces the distribution of radiolabeled molecules in experimental animals and human subjects. We hypothesized that PET could be used to visualize the binding of the bronchodilator drug ipratropium to muscarinic receptors (MR) in the lungs of living non-human primates (NHP). The objectives of this study were two-fold: (i) to develop a methodology for quantitative imaging of muscarinic receptors in NHP lung and (ii) to estimate and compare ipratropium-induced MR occupancy following drug administration via intravenous injection and inhalation, respectively.Methods: A series of PET measurements (n=18) was performed after intravenous injection of the selective muscarinic radioligand C-11-VC-002 in NHP (n=5). The lungs and pituitary gland (both rich in MR) were kept in the field of view. Each PET measurement was followed by a PET measurement preceded by treatment with ipratropium (intravenous or inhaled).Results: Radioligand binding was quantified using the Logan graphical analysis method providing the total volume of distribution (V-T). Ipratropium reduced the V-T in the lung and pituitary in a dose-dependent fashion. At similar plasma ipratropium concentrations, administration by inhalation produced larger reductions in V-T for the lungs. The plasma-derived apparent affinity for ipratropium binding in the lung was one order of magnitude higher after inhalation (K-iih=1.01nM) than after intravenous infusion (K-iiv=10.84nM).Conclusion: Quantitative muscarinic receptor occupancy imaging by PET articulates and quantifies the therapeutic advantage of the inhaled route of delivery and provides a tool for future developments of improved inhaled drugs.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)

Nyckelord

PET
Lungs
Muscarinic receptors
Ipratropium

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy